Increased plasma concentrations of lipoprotein(a) for every phenotype of apolipoprotein(a) in patients with chronic renal failure treated by hemodialysis

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 6, Issue 4, 1996, Pages 203-210

  Gazzaruso, C ^a   Bonetti, G ^a   Garzaniti, A ^a   Pini, G ^a   Ragazzoni, A ^a   Bianchi, C ^a   Jucci, A ^a   Buscaglia, P ^a   Geroldi, D ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Apolipoprotein(a); Chronic renal failure; Hemodialysis; Lipoprotein(a)

Indexed keywords

EID: 0013485192     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM (1986) Association of levels of lipoprotein (a), plasma lipid and other lipoproteins with coronary artery disease documented by angiography. Circulation 74: 758-765
2. Rhoads GG, Dahlen GH, Berg K, Morton NE, Dannenberg AL (1986) Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256: 2540-2544
3. Hoefler G, Harnoncourt F, Paschke E, Mirti W, Pfeiffer KH, Kostner GM (1988) Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis 8: 398-401
4. Scanu AM (1993) Lipoprotein(a): a genetic risk factor for premature coronary heart disease. JAMA 267: 3326-3329
5. Hoff HF, O' Neal J, Yashiro A (1993) Partial characterization of lipoproteins containing apo(a) in human atherosclerotic lesions. J Lipid Res 34: 789-798
6. Mc Lean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM (1987) DNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 300: 132-137
7. Eaton DL, Fless GM, Kohr WJ, McLean JW, Xu QT, Miller CG, Lawn RM, Scanu AM (1987) Partial aminoacids sequence of apolipoprotein (a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 84: 3224-3232
8. Loscalzo J (1990) Lipoprotein (a). A unique risk factor for atherothrombotic disease. Arteriosclerosis 10: 672-673
9. Scott J (1991) Lipoprotein (a). Thrombotic and atherogenic. BMJ 303: 663-664
10. Ilyas Kamboh M, Ferrel L, Kottke BA (1991). Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet 49: 1063-1074
11. Scanu AM, Fless GM (1990) Lipoprotein(a). Heterogeneity and biological relevance. J Clin Invest 85: 1709-1715
12. Utermann G, Menzel HG, Kraft HG, Dub HC, Kemmler HG, Seit C (1987) Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a) lipoprotein concentrations in plasma. Clin Invest 80: 458-465
13. Boerwinkle E (1992) Genetics of plasma lipoprotein(a) concentrations. Curr Opin Lipid 3: 128-136
14. Boerwinkle E, Leffert CC, Lin C, Lackner G, Chiea G, Hobbs HH (1992) Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. Clin Invest 90: 52-60
15. Boerwinkle E, Menzel HJ, Kraft HJ, Utermann G (1989) Genetics of the quantitative Lp(a) lipoprotein trait. Hum Genet 82: 73-78
16. Attman PO, Alaupovic P (1991) Lipid and apolipoprotein profiles of uremic dyslipoproteinemia -relation to renal function and dialysis. Nephron 57: 401-410
17. Attman PO, Alaupovic P (1991) Lipid abnormalities in chronic renal insufficiency. Kidney Int 39: S16-S23
18. Sentì M, Romero R, Pedro-Botet J, Pelegrì A, Nogues X, Rubies-Prat (1992) Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 41: 1394-1399
19. Joven J, Viell E, Ahmad S, Cheung MC, Brunzell JD (1993) Lipoprotein heterogeneity in end-stage renal disease. Kidney Int 43: 410-418
20. Guijarro C, Keane WF (1993) Lipid abnormalities and change in plasma proteins in glomerular diseases and chronic renal failure. Curr Opin Nephrol Hypertens 2: 372-379
21. Maggi E, Bellazzi R, Falaschi F, Frattoni A, Pereni G, Finardi G, Gazo A, Romanini L, Bellomo G (1994) Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis ? Kidney Int 45: 876-883
22. Goldberg AP, Harter HR, Patsch W, Schechtman KB, Province M, Weerts C, Kuisk I, McCrate MM, Schonfeld G (1983) Racial differences in plasma high density lipoproteins in patients receiving haemodialysis. A possible mechanism for accelerated atherosclerosis in white men. New Engl J Med 308: 1245-1252
23. Rostand SG, Kirk KA, Rutsky EA (1982) Relations of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 22: 304-308
24. Grundy SM (1990) Management of hyperlipidemia of kidney disease. Kidney Int 37: 847-853
25. Parra HJ, Mezdour H, Cachera C, Dracon M, Tacquet A, Fruchart JC (1987). Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem 33: 721
26. Parsy D, Dracon N, Cachera C, Parra HG, Vanhoutte G, Tacquet A, Fruchart JC (1988) Lipoprotein abnormalities in chronic hemodialysis patients. Nephrol Dial Transplant 3: 51-56
27. Kandoussi A, Cacher C, Dagnies D, Dracon M, Fruchart JC, Tacquet A (1992) Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD. Kidney Int 42: 424-425
28. Cressman M, Heyka RJ, Paganini EP, O'Neil J, Skibinski C, Hoff HF (1992) Lipoprotein(a) is an indipendent risk factor for cardiovascular disease in hemodialysis patients. Circulation 86: 475-482
29. Hirata K, Kikuchi S, Saku K, Jimi S, Zhang B, Naito S, Hamaguchi H, Arakaw K (1993) Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus. Kidney Int 44: 1062-1070
30. Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, Konig P (1993) Elevated plasma concentrations of Lipoprotein(a) in patients with End-Stage Renal Disease are not related to the size polymorphism of apolipoprotein(a). Clin Invest 91: 397-401
31. Auguet T, Senti M, Rubies Prat J, Pelegrì A, Pedro-Botet J, Nogues X, Romero R (1993) Serum lipoprotein(a) concentration in patients with chronic renal failure receiving hemodialysis: influence of apolipoprotein(a) polymorphism. Nephrol Dial Transplant 8: 1099-1103
32. Garzaniti A, Bonetti G, Buscaglia P, Vill RF, Giudici A, Gazzaruso C, Pozzi M, Geroldi D, Finardi G (1994) Evidences for a non genetic nature of high Lp(a) levels in hemodialysis patients. Abs. Ital J Biochem 43: 302A-303A
33. Kronenberg F, Konig P, Lhotta K, Ofner D, Sandholzer C, Margreiter R, Dosch E, Utermann G, Dieplinger H (1994) Apolipoprotein(a) phenotype-associated decrease in Lipoprotein(a) plasma concentrations after renal transplantation. Arterioscl Thromb 14: 1399-1404
34. Friedewald WT, Lewy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502
35. Li KM, Wilcken DEL, Dudman NPB (1994) Effect of serum lipoprotein(a) on estimation of low density cholesterol by the Friedewald formula. Clin Chem 40: 571-573
36. Geroldi D, Bellotti V, Buscaglia P, Bonetti G, Gazzaruso C, Caprioli A, Fratino P (1993) Characterization of apo(a) polymorphism by modified immunoblotting technique in an Italian population sample. Clin Chim Acta 221: 159-169
37. Gazzaruso C, Buscaglia P, Garzaniti A, Bonetti G, Savino S, Mariotti S, Jucci A, Finardi G, Geroldi (1996). Lp(a) plasma concentrations, apo(a) polymorphism and family history of coronary heart disease in patients with essential hypertension. J Cardiovasc Risk, in press
38. Buscaglia P, Gazzaruso C, Garzaniti A, Bonetti G, Fratino P, Geroldi D (1995). Lipoprotein(a), apolipoprotein(a) polymorphism and insulin treatment in type II diabetic patients. Letter. Diabetes Care 18: 1202-1203
39. Kikuchi S, Nakagawa A, Kobayashi K, Li L, Yanagi H, Arinami T, Kozu Y, Miyazaki R, Tsuchiya S, Hamaguchi H (1993), High degree of genetic polymorphism in apolipoprotein(a) associated with plasma lipoprotein(a) levels in Japanese and Chinese populations. Hum Genet 92: 537-544
40. Cappelletti A, Priori F, Gazzaruso C, Malberti F, Cosci P, Barbisoni P, Imbasciati E, Geroldi D (1992) Clinical Significance of Lipoprotein (a) -Lp(a)- in Chronic Renal Failure treated by hemodialysis. Abs. Lipids in Medicine 92, Italy-USA conference. Bologna (Italy), 10-12 May 1992